CAPR stock forecast
Our latest prediction for Capricor Therapeutics, Inc.'s stock price was made on the May 9, 2017 when the stock price was at 2.90$.
In the short term (2weeks), CAPR's stock price should outperform the market by 4.75%. During that period the price should oscillate between -9.14% and +13.78%.
In the medium term (3months), CAPR's stock price should outperform the market by 7.53%. During that period the price should oscillate between -21.28% and +39.20%.Get email alerts
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a profit of 0.12$ per share.
The book value per share is 0.31$
Three months stock forecastMay 9, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|